Related Experiment Video
Updated: Jul 7, 2026
Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis
Published on: January 17, 2025
[N01WA-735E, a human leukocyte elastase inhibitor from metabolites of microorganisms]
Ya-Shan Wei1, Hua Zhang, Xin-Hua Lu
1College of Life Science, Hebei Normal University Shijiazhuang 050016, China.
Abstract:
Human leukocyte elastase is an important selection target of inflammation and cancer. In this paper, a high throughput screening model was established for screening human leukocyte elastase inhibitors from thousands of strains of actinomycetes. As a result, a strain, N01WA-735 with potent suppression activity was isolated. Firstly, the strain N01WA-735 was identified as Streptomyces according to morphology and biochemical analysis. The Streptomyces N01WA-735 was processed by solvent extraction, silica column chromatography, Sephadex LH-20 column chromatography and crystallization to get a pure active compound named N01WA-735E. Its chemical structure was elucidated as the same as that of the compound named BE-52440A by physicochemical properties and spectral data of UV, MS, 1H-NMR and 13C-NMR respectively. The compound showed a strong inhibitory activity against human leukocyte elastase with IC50 of 3.02 micromol/L. The compound is reported as a human leukocyte elastase inhibitor for the first time.
Insights
Researchers discovered a novel Streptomyces compound, N01WA-735E, that potently inhibits human leukocyte elastase. This finding offers a new avenue for developing treatments targeting inflammation and cancer.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Context:
- Human leukocyte elastase (HLE) is a key enzyme implicated in inflammatory diseases and cancer progression.
- Identifying potent and selective HLE inhibitors is crucial for therapeutic development.
- Natural products, particularly from microbial sources, represent a rich resource for novel drug discovery.
Purpose:
- To establish a high-throughput screening (HTS) model for identifying HLE inhibitors from actinomycetes.
- To isolate and characterize a novel HLE inhibitor from a microbial strain.
- To evaluate the inhibitory activity of the isolated compound against HLE.
Summary:
- A HTS model was developed to screen thousands of actinomycetes strains for HLE inhibitory activity.
- A potent HLE inhibitor, designated N01WA-735E, was isolated from Streptomyces strain N01WA-735.
- The chemical structure of N01WA-735E was elucidated and confirmed to be identical to BE-52440A. It demonstrated strong HLE inhibition with an IC50 of 3.02 µmol/L.
Impact:
- This study reports N01WA-735E as a novel inhibitor of human leukocyte elastase.
- The discovery provides a new lead compound for the development of HLE-targeted therapies for inflammatory conditions and cancer.
- The established HTS model can be utilized for future screening of microbial libraries for other enzyme inhibitors.
